Close Menu

NEW YORK (GenomeWeb) – Prescient Medicine Holdings said today that it has acquired privately held molecular diagnostics firm AutoGenomics for an undisclosed amount.

AutoGenomics, based on Carlsbad, California, has developed and commercialized the Infiniti platform, a US Food and Drug Administration 510(k)-exempt automated microarray-based diagnostic system with applications in personalized medicine, pain management, cardiovascular health, mental health, women's health, oncology, infectious diseases, and genetic disorders.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.